ReNAgade Therapeutics
Cambridge, United States· Est.
ReNAgade Therapeutics is a biotechnology company developing RNA medicines with novel delivery platforms to target a wide range of tissues and diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $1.2B
About
ReNAgade Therapeutics is a biotechnology company developing RNA medicines with novel delivery platforms to target a wide range of tissues and diseases.
RNA TherapeuticsGene TherapyDrug Delivery
Funding History
4Total raised:$1.2B
Series D$300M
Series C$300M
Series B$300M
Series A$300M